| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 51.4K | $1.39M | - | |
| CFO | 18.1K | $490.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2019 | Thomas Andrew Crockett72 | CEO | Sell | 10,000 | $17.04 | $170,407.00 | -3.9% | |
| Apr 22, 2019 | Christopher Yea53 | Chief Development Officer | Sale+OE | 7,355 | $26.04 | $191,529.84 | -8.1% | |
| Apr 22, 2019 | Benjamin L Palleiko46 | Cbo, CFO and Secretary | Sale+OE | 3,073 | $25.70 | $78,976.41 | -8.6% | |
| Apr 17, 2019 | Edward P. Feener72 | Chief Scientific Officer | Sell | 4,000 | $24.92 | $99,666.27 | -3.8% | |
| Apr 15, 2019 | Thomas Andrew Crockett72 | CEO | Sell | 10,000 | $24.80 | $247,957.72 | -3.7% | |
| Apr 10, 2019 | Svlsf IV, LLC | 10% Owner | Sell | 50,000 | $29.20 | $1,460,145.18 | -51.3% | |
| Apr 5, 2019 | Andreas Maetzel73 | Senior Vice President Medical | Sale+OE | 5,000 | $30.00 | $150,011.00 | - | |
| Apr 2, 2019 | Svlsf IV, LLC | 10% Owner | Sell | 97,074 | $28.03 | $2,720,896.65 | -66.5% | |
| Mar 28, 2019 | Svlsf IV, LLC | 10% Owner | Sell | 124,675 | $28.84 | $3,596,032.22 | -70.8% | |
| Mar 18, 2019 | Svlsf IV, LLC | 10% Owner | Sell | 262,470 | $26.70 | $7,007,949.00 | -82.7% |